Telomir Pharmaceuticals, Inc. Common Stock (NASDAQ: TELO) last traded at $1.10, down 0.27% on the session. The quote above updates while this page is open; the figures below are drawn from Telomir Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Telomir Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker TELO. Its market capitalisation is $75.45 million.
Valuation measures for Telomir Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $75.45M |
|---|---|
| Enterprise value | $75.02M |
| Price / book | 14.99 |
| Beta | 1.72 |
Trailing-twelve-month figures tagged in Telomir Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$5.88M |
| Return on equity | -116.74% |
|---|
| Cash | $754.3K |
|---|
Range and volume for TELO over the past 52 weeks.
| 52-week high | $1.75 |
|---|---|
| 52-week low | $0.888 |
| Volume | 27.4K |
| Average volume | 97.0K |
| Previous close | $1.10 |
Invest a chosen dollar amount in Telomir Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TELO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.